SCHEMBL6544217

SCHEMBL6544217

CC(Oc1ccc(CC2SC(=O)NC2=O)cc1)c1nc2ccc(Oc3ccccn3)cc2[nH]1

nearest known ligand 0.47

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PPARG P37231 13/20 0.47
FFAR1 O14842 8/20 0.46
PPARA Q07869 3/20 0.46
RARG P13631 1/20 0.43
RXRA P19793 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6544449 0.88 PPARG (0.46) PPARGFFAR1PPARA
SCHEMBL6544497 0.87 FFAR1 (0.49) PPARGFFAR1PPARA
SCHEMBL6543708 0.87 FFAR1 (0.45) PPARGFFAR1PPARA
Hydrochloric Acid SCHEMBL6543808 0.86 FFAR1 (0.48) PPARGFFAR1PPARA
Hydrochloric Acid SCHEMBL6544335 0.86 FFAR1 (0.44) PPARGFFAR1PPARA
SCHEMBL7241918 0.86 FFAR1 (0.54) PPARGFFAR1PPARA
SCHEMBL6543635 0.86 PPARG (0.49) PPARGFFAR1PPARA
SCHEMBL6543694 0.86 PPARG (0.46) PPARGFFAR1PPARA
Hydrochloric Acid SCHEMBL6544507 0.85 THRA (0.44) PPARGFFAR1PPARA
SCHEMBL6544205 0.85 PPARG (0.42) PPARGFFAR1PPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1022272-B1 SUBSTITUTED FUSED HETEROCYCLIC COMPOUNDS SANKYO CO (JP) 2004-05-26 EP claimed
US-6432993-B1 BENZIMIDAZOLE OR IMIDAZO(4,5-B)PYRIDINE DERIVATES; IMMUNOMODULATORS; ALDOSE REDUCTASE AND LIPOXYGENASE INHIBITORS; DIABETES; PREVENTS LIPID PEROXIDATION; ANTILIPEMIC, HYPOTENSIVE AGENTS SANKYO COMPANY, LIMITED (JP) 2002-08-13 US claimed
EP-1022272-A1 SUBSTITUTED FUSED HETEROCYCLIC COMPOUNDS Sankyo Company Limited (JP) 2000-07-26 EP claimed
EP-1022272-B1 SUBSTITUTED FUSED HETEROCYCLIC COMPOUNDS SANKYO CO (JP) 2004-05-26 EP disclosed
US-6432993-B1 BENZIMIDAZOLE OR IMIDAZO(4,5-B)PYRIDINE DERIVATES; IMMUNOMODULATORS; ALDOSE REDUCTASE AND LIPOXYGENASE INHIBITORS; DIABETES; PREVENTS LIPID PEROXIDATION; ANTILIPEMIC, HYPOTENSIVE AGENTS SANKYO COMPANY, LIMITED (JP) 2002-08-13 US disclosed
EP-1022272-A1 SUBSTITUTED FUSED HETEROCYCLIC COMPOUNDS Sankyo Company Limited (JP) 2000-07-26 EP disclosed